Mereo BioPharma
As of the edition of 20 October 2026, Mereo BioPharma runs 11 drugs; it is on route A at 12 targets and on route B at 0 targets.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
- OncoMed Pharmaceuticals, Inc.: acquired
Drugs by status
| Status | Count |
|---|---|
| Active | 1 |
| Went quiet | 7 |
| Stopped | 3 |
| Total | 11 |
Where it needs a new molecule
Route A at 12 targets, route B at 0 targets.
All 12 rows on route A or B
In the product12 company-target rows on route A or B; 9 are not shown here, and no score is.
See all 12 targets where Mereo BioPharma needs a new molecule, with the facts behind eachRequest access. Nothing is shown until you do.
Where its trials are
- Cancer: 22 trials led
- Digestive system: 10 trials led
- Hormones: 9 trials led